←
Lauren E. Colbert, MD MSCR1,358 posts
Lauren E. Colbert, MD MSCR avatar

Lauren E. Colbert, MD MSCR

@colbertle

physician-scientist, GYN brachytherapist @mdandersonnews. #biostats nerd. we study tumor and vaginal #Microbiome, #HPV. Proud girl mom.

◷ Joined September 2014▧ 123 Photos and videos
Chelsea C Pinnix MD PhD avatar
⟳ Lauren E. Colbert, MD MSCR retweeted
Chelsea C Pinnix MD PhD@ChelseaPinnix·1 Oct 2024

Brilliant presentation by @MDAndersonNews #RadOnc PGY5 resident @BenjaminSchrank today. This is the FIRST antibody-drug conjugate specifically designed to enhance immune activation against cancer. LET’S GOOOO! @wenjiang_nano @BettyKimLab @ACKoongMDPhD #ASTRO24

Post attachment

Dr. Benjamin Schrank explains his recent research on a first-in-class antibody-drug conjugate that is designed to trigger an immune response, as a complementary strategy to radiation therapy. Read more: bit.ly/3XXRmWW @BenjaminSchrank #ASTRO24 #EndCancer

0:32
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE avatar
⟳ Lauren E. Colbert, MD MSCR retweeted
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE@BettyKimLab·1 Oct 2024

@BenjaminSchrank is without a doubt one of the very best physician scientist trainee I have ever encountered. Quadruple threat: great scientist, leadership skills, gifted educator and super kind/humble. Truly exceptional. He’s also on the job market. So proud!

Lauren E. Colbert, MD MSCR avatar
Lauren E. Colbert, MD MSCR@colbertle·30 Sep 2024

Fantastic work by one of our PGY5 aspiring physician scientists! @Vince_BernPag is the real deal and a total phys sci superstar - it’s amazing to see this project develop from the beginning to these great discoveries and looking forward to how his work will impact patients

Congrats to @MDAndersonNews #RadOnc PGY5 Holman pathway resident @Vince_BernPag on this compelling work exploring molecular processes related to response to RT via longitudinal tumor biopsies for pts with pancreatic cancer before & after SBRT.@ACKoongMDPhD @PrajnanDasMD #ASTRO24

Post attachmentPost attachmentPost attachment
UT MD Anderson avatar
⟳ Lauren E. Colbert, MD MSCR retweeted
UT MD Anderson@UTMDAnderson·27 Sep 2024

A first-in-class antibody-drug conjugate works by targeting protein CD47, which helps immune cells activate and engulf cancer cells. The drug triggers an adaptive immune response to help eliminate the tumor. Learn more about the research, which Dr. Ben Schrank will present at #ASTRO24: bit.ly/3XXRmWW #EndCancer